leisure time
Previous article:
BioMarin wins approval for gene therapy to treat hemophilia A
Next article: JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology
Next article: JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology
entertainment
leisure time
-
Readout LOUD podcast: 2023 in review, and a look at biotech in 2024
2025-09-29 22:41 -
Shkreli is convicted of fraud. Can pharma finally slam the door on him?
2025-09-29 22:36 -
Police still searching for prisoner who escaped from NYC hospital
2025-09-29 22:02 -
Risky weight loss products often used by teens globally, per study
2025-09-29 21:06 -
Methadone doses haven’t kept up in the age of fentanyl
2025-09-29 20:50 -
Maui's cultural, historic landmarks damaged in the devastating wildfires
2025-09-29 20:22